These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2144918)

  • 1. Contribution of platelets to increased plasminogen activator inhibitor type 1 in severe preeclampsia.
    Gilabert J; Estellés A; Aznar J; España F; Andrés C; Santos T; Vallés J
    Thromb Haemost; 1990 Jun; 63(3):361-6. PubMed ID: 2144918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coagulation and fibrinolysis variables in pregnant women with type 1 diabetes mellitus.
    Bronisz A; Rosc D; Bronisz M; Szymanski W; Junik R
    Med Sci Monit; 2008 Nov; 14(11):CR574-9. PubMed ID: 18971874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Endothelial damage and blood coagulation activation in preeclampsia].
    Stella A; Babbo GL; Grella PV
    Minerva Ginecol; 1998 Nov; 50(11):463-8. PubMed ID: 9882986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the release of a plasminogen activator inhibitor by human platelets.
    Kruithof EK; Tran-Thang C; Bachmann F
    Thromb Haemost; 1986 Apr; 55(2):201-5. PubMed ID: 2940723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic activity and protein C in preeclampsia.
    Aznar J; Gilabert J; Estellés A; España F
    Thromb Haemost; 1986 Jun; 55(3):314-7. PubMed ID: 3092388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet aggregation and TGF-beta(1) plasma levels in pregnant women with preeclampsia.
    Peraçoli MT; Menegon FT; Borges VT; de Araújo Costa RA; Thomazini-Santos IA; Peraçoli JC
    J Reprod Immunol; 2008 Oct; 79(1):79-84. PubMed ID: 18805591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
    Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
    J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasminogen activators, plasminogen activator inhibitors and markers of intravascular coagulation in pre-eclampsia.
    Koh SC; Anandakumar C; Montan S; Ratnam SS
    Gynecol Obstet Invest; 1993; 35(4):214-21. PubMed ID: 8330765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and haemostatic parameters in the HELLP syndrome: relevance of plasminogen activator inhibitors.
    Gilabert J; Estellés A; Ridocci F; España F; Aznar J; Galbis M
    Gynecol Obstet Invest; 1990; 30(2):81-6. PubMed ID: 2147163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticle-associated P-selectin reflects platelet activation in preeclampsia.
    Lok CA; Nieuwland R; Sturk A; Hau CM; Boer K; Vanbavel E; Vanderpost JA
    Platelets; 2007 Feb; 18(1):68-72. PubMed ID: 17365856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies.
    Catarino C; Rebelo I; Belo L; Rocha S; Castro EB; Patricio B; Quintanilha A; Santos-Silva A
    Thromb Res; 2008; 123(2):219-24. PubMed ID: 18384840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of fibrinolytic capacity by a combined assay system for tissue-type plasminogen activator antigen and function using monoclonal anti-tissue-type plasminogen activator antibodies.
    Wojta J; Turcu L; Wagner OF; Korninger C; Binder BR
    J Lab Clin Med; 1987 Jun; 109(6):665-71. PubMed ID: 3108431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased global fibrinolytic capacity as a clue for activated fibrinolysis in pre-eclampsia.
    Sucak GT; Acar K; Sucak A; Kirazli S; Haznedar R
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):347-52. PubMed ID: 16788310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia.
    Estellés A; Gilabert J; Aznar J; Loskutoff DJ; Schleef RR
    Blood; 1989 Sep; 74(4):1332-8. PubMed ID: 2504307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation Abnormalities in Liver Cirrhosis.
    Violi F; Ferro D; Basili S; Quintarelli C; Musca A; Cordova C; Balsano F
    Hepatology; 1993 Jan; 17(1):78-83. PubMed ID: 8423044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of the hemostasis parameters in the development of preeclampsia.
    Ho CH; Yang ZL
    Thromb Haemost; 1992 Feb; 67(2):214-8. PubMed ID: 1621241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia.
    Estellés A; Gilabert J; España F; Aznar J; Galbis M
    Am J Obstet Gynecol; 1991 Jul; 165(1):138-42. PubMed ID: 1906680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and platelet norepinephrine in normal and preeclamptic pregnancy.
    O'Shaughnessy R; Reiss R; Scott-Tibbs G; McSweeney E
    J Reprod Med; 1987 Jul; 32(7):504-8. PubMed ID: 3625614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mean platelet volume of normal pregnant women and severe preeclamptic women in Siriraj Hospital.
    Boriboonhirunsarn D; Atisook R; Taveethamsathit T
    J Med Assoc Thai; 1995 Nov; 78(11):586-9. PubMed ID: 8576668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.